Journal
NEUROCHEMICAL JOURNAL
Volume 5, Issue 3, Pages 220-222Publisher
MAIK NAUKA/INTERPERIODICA/SPRINGER
DOI: 10.1134/S1819712411030135
Keywords
Alzheimer's disease; blood-brain barrier; electronic microscopy; Evans blue; APP/PS1; transgenic
Categories
Ask authors/readers for more resources
The present work explored the blood-brain barrier (BBB) changes in a mice model of Alzheimer's disease (AD) (APP/PS1 double mutant). The transgenic mice model showed overexpression of A beta 1-42 in the brain and the loss of learning functions. The test with tail vein injection of Evans Blue (EB) showed more EB fluorescence in the brain tissue, suggesting an increased BBB permeability. Additionally, Electronic microscope (EM) images showed changes in base membrane, vessel-associated glial cells, pericytes, and endothelial cells. This work supported the BBB dysfunction hypothesis in AD, and suggested that APP/PS1 mice could be a suitable model in testing BBB-crossing drugs of AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available